MedTrace Logo

Intra-articularInjection of Botulinum Toxin Type

NCT00211679 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2005-09-21

No results posted yet for this study

Summary

The purpose of this study is to determine whether intra-articular injection of botulinum toxin is effective in the treatment of chronic knee paindue to arthritis.

Conditions

Interventions

DRUG

Botulinum Toxin Type A

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Center for Veterans Research and Education

    collaborator OTHER

  • Minneapolis Veterans Affairs Medical Center

    lead FED

Principal Investigators

  • Maren L Mahowad, MD · Minneapolis VAMC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00211679 on ClinicalTrials.gov